Innate Pharma Competitors and Similar CompaniesClear all
Innate Pharma's competitors and similar companies include Ablynx and Gamida Cell.
 Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. |  Gamida Cell Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases. | |
Founding Date | Founding Date 1999 | Founding Date 2001 | Founding Date 1998 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Marseille, FR HQ Rockville, US | Locations Gent, BE HQ | Locations Boston, US HQ Jerusalem, IL |
Employees | Employees 181 | Employees 1252% decrease | Employees 143175% increase |
Valuation ($) | Valuation ($) 148.6 m | Valuation ($) N/A | Valuation ($) 4.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) €2.8m (FY, 2025) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) $1.8m (FY, 2023) |
Cost of goods | Cost of goods €266k (FY, 2025) | Cost of goods N/A | Cost of goods $1.5m (FY, 2023) |
Gross profit | Gross profit €8.7m (FY, 2025) | Gross profit N/A | Gross profit $330k (FY, 2023) |
Net income | Net income (€49.2m) (FY, 2025) | Net income (€1.1m) (FY, 2016) | Net income ($63m) (FY, 2023) |
Operating ⚠ | |||
Patients Reached | Patients Reached N/A | Patients Reached 2 k (Q2, 2017) | Patients Reached 120 (Q3, 2018) |
Funding | |||
Total funding raised | Total funding raised $ 94.1m | Total funding raised $ 498.8m | Total funding raised $ 128.3m |
For sources of this data, please see the company profile
View Company Profiles
Ablynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View companyGamida Cell
HQ
Boston, US
Employees
143
Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases.
View company